Osseointegration Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030

Osseointegration Implants Market By Type (Dental Implants, Limb Implants, Hip Implants, And Spinal Implants), Material (Stainless Steel, Ceramic, Titanium, And Zirconia), End-Users (Hospitals, Orthopedic Clinics, Dental Clinics, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to the growing prevalence of orthopedic conditions, increasing prevalence of dental disorders, and increase in product approvals across the globe.

The osseointegration implants market is estimated to grow at a CAGR of 7.11% during the forecast period from 2024 to 2030. The demand for osseointegration implants is primarily being boosted by the increasing prevalence of orthopedic conditions. Additionally, the growing number of dental disorders, and the increasing surge in product approval activities reflects advancements in orthopedic and dental technology, improving patient outcomes and thus expanding the market for osseointegration implants during the forecast period from 2024 to 2030.

Osseointegration Implants Market Dynamics

According to the latest data provided by the World Health Organization (WHO) (2023), approximately 528 million people globally were living with osteoarthritis and 18 million people are living with rheumatoid arthritis. The knee is the most commonly affected joint, with 365 million cases, followed by the hip and hand joints. Thus, the increasing cases of arthritis and rheumatoid arthritis significantly contribute to the market growth of osseointegration implants due to their impact on joint health and function.

Additionally, as per the data provided by the Organization for Economic Co-operation and Development (OECD), in 2021 the number of knee replacements in Switzerland was 273 per 100,000 population, in Finland the number of knee replacements was higher in 2021, estimating to 260 knee replacement per 100,000 population. Thus, the increase in knee replacement can further boost the market of osseointegration implants globally.

Moreover, the rise in road traffic accidents is another major factor leading to the rising demand of osseointegration implants. According to the recent data provided by World Health Organization (WHO) (2023), approximately 20 to 50 million people suffer non-fatal injuries, with many incurring a disability in road traffic injuries. Injuries sustained in road accidents can include traumatic amputations, severe fractures, and joint damage, which may necessitate the use of advanced orthopedic solutions like osseointegration implants thereby boosting its market.
According to the recent data provided by World Health Organization (WHO) (2023) globally, in 2022, approximately 2 billion people had caries in permanent teeth, and 514 million children had caries in primary teeth. Complete tooth loss affects nearly 7% of people aged 20 years and older, increasing to 23% among those aged 60 years and older. Tooth loss can be psychologically traumatic, socially damaging, and functionally limiting. Thus, increase in cases of dental disorders can boost the market of osseointegration implants as it can provide a durable solution by anchoring directly to the jawbone, offering stability and function similar to natural teeth.

However, the risk of infection from dental and bone osseointegration implants caused due to bacterial exposure and poor oral hygiene and increased surgical complexity may result in slight obstacle to the growth of osseointegration implants market.

Osseointegration Implants Market Segment Analysis:

Osseointegration implants market by Type (Dental Implants, Limb Implants, Hip Implants, and Spinal Implants), Material (Stainless Steel, Ceramic, Titanium, and Zirconia), End-Users (Hospitals, Orthopedic Clinics, Dental Clinics, and others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the type segment of the osseointegration implants market, the dental implants category is estimated to a mass a significant revenue share in the osseointegration implants market in 2023. Dental implants play a significant role in promoting the overall market of osseointegration implants more than any other type. Dental implants are among the most commonly performed osseointegration procedures. The demand for dental implants is consistently high due to the prevalence of tooth loss from factors like dental caries, trauma, and periodontal disease. Additionally, increasing innovations in the implant design, such as surface coatings and CAD/CAM (Computer-Aided Design/Computer-Aided Manufacturing) technology, have improved success rates and patient outcomes. Further, dental implants are also used to provide functional and aesthetic benefits that are comparable to natural teeth, contributing to their popularity among patients and dentists.
Furthermore, the increasing regulatory approval encourages surgeons to adopt dental implants by validating the technology's effectiveness and reliability, leading to increased utilization of dental implants practices. For instance, in June 2022 ZimVie Inc., a prominent life sciences focusing on dental and spine treatments, introduced two new dental solutions. The T3® PRO Tapered Implant and the Encode® Emergence Healing Abutment are the newest products in ZimVie’s lineup. The T3 PRO Tapered Implant builds on the reliable design of the T3 Tapered Implant, providing advanced options for dental implant treatments.

Therefore, according to the above mentioned factors and increasing product approvals of dental implants will register significant growth of the category, thereby driving the growth of the overall osseointegration implants market during the forecast period.

North America Is Expected To Dominate The Overall Osseointegration Implants Market:

North America is expected to account for the highest proportion of the osseointegration implants market in 2023, out of all regions. The market for osseointegration implants in the North America is driven by several key factors such as orthopedic and dental disorders due to conditions such as osteoarthritis, osteoporosis, and tooth loss. Additionally, increasing technological advancements, and a viable market in terms of product approval and product launches will further boost the market for osseointegration implants.

As per the American College of Prosthodontists 2022, more than 36 million Americans do not have any teeth, and 120 million people in the US are missing at least one tooth in 2020. These numbers are expected to grow in the next two decades.
Moreover, as per the American College of Prosthodontists 2022, in the geriatric population, the ratio of edentulous individuals is 2 to 1. About 23 million are completely edentulous and about 12 million are edentulous in one arch. The number of partially edentulous patients will continue to increase in the next 15 years to more than 200 million individuals. Partial edentulism affects the majority of adult Americans. Thus, the increasing cases of dental disorders can escalate the market of osseointegration implants as these disorders often lead to the need for tooth replacement, thus increasing the demand of osseointegration implants.

As per the recent data provided by Centre for Disease Control and Prevention (CDC) (2023), during 2019 to 2021, statistics revealed that about 21.2% of adults in the United States, totaling approximately 53.2 million individuals, were diagnosed with arthritis by a healthcare professional. Among these, women experienced a higher prevalence, with 20.9% affected, compared to 16.3% of men. Moreover, veterans exhibited a higher prevalence of arthritis at 24.2%, surpassing the 18.5% prevalence rate among non-veterans. Additionally, the likelihood of being diagnosed with arthritis increased with age. These conditions often lead to severe joint pain, deformities, and loss of function, necessitating advanced medical interventions such as joint replacements and osseointegration implants thereby boosting the future market in the United States.

Additionally, increasing product approval by regulatory bodies will also help to drive the growth of the osseointegration implants. For instance, in August 2023, RevBio, Inc. received FDA approval to conduct its second U.S.-based clinical trial for dental implant stabilization.

Thereby the factors mentioned are collectively responsible in escalating the overall market of osseointegration implants in the region during the forecast period.

Osseointegration Implants Market Key Players:

Some of the key market players operating in the osseointegration implants market include Medtronic, Stryker, Neoss, Onkos Surgical, CartiHeal Ltd., RevBio, Inc., ZimVie Inc., Zimmer Biomet, OSSTEM IMPLANT CO., LTD., CONMED Corporation., Smith & Nephew, BioHorizons, Camlog, Straumann AG Group, Align Technology, Inc., BEGO GmbH and Co. KG, MEGA’GEN IMPLANT CO.,LTD., Henry Schein, Inc., MIS Implants Technologies, Nobel Biocare, and others.

Recent Developmental Activities In The Osseointegration Implants Market:

• In April 2024, Onkos Surgical announced the first FDA De Novo approval for an antibacterial coating specifically designed for tumor and revision orthopedic implants.
• In September 2023, Neoss® Group introduced a new Multi-Unit Abutment as part of their Neoss4+™ Treatment Solution for dental implants. This abutment includes a 10-degree option with a shorter vertical height. It also features a clinical screw fixed within the abutment to prevent it from getting lost during placement.
• In December 2022, NYU Langone’s Center for Amputation Reconstruction launched osseointegration program with FDA-approved implant system.
• In March 2022, CartiHeal Ltd. received the FDA approval for Agili-C™ implant for the treatment of knee joint surface lesions, chondral and osteochondral defects.

Takeaways From The Osseointegration Implants Market Report Study

• Market size analysis for current osseointegration implants size (2023), and market forecast for 6 years (2024-2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the osseointegration implants market.
• Various opportunities available for the other competitors in the osseointegration implants market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current osseointegration implants market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for osseointegration implants market growth in the coming future?

Target Audience Who Can Be Benefited From This Osseointegration Implants Market Report Study

• Osseointegration implants product providers
• Research organizations and consulting companies
• Osseointegration implants-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in osseointegration implants
• Various end-users who want to know more about the osseointegration implants market and the latest technological developments in the osseointegration implants market.

Frequently Asked Questions For The Osseointegration Implants Market:

1. What are osseointegration implants?

Osseointegration implants are medical devices designed to be permanently anchored into the bone. This process involves the direct structural and functional connection between the living bone and the surface of the implant. Osseointegration is commonly used in dental and orthopedic applications, providing stable and durable solutions for various conditions.

2. What is the market for osseointegration implants?

The osseointegration implants market is estimated to grow at a CAGR of 7.11% during the forecast period from 2024 to 2030.

3. What are the drivers for the global osseointegration implants market?

The demand for osseointegration implants is primarily being boosted by the increasing prevalence of orthopedic conditions. Additionally, growing number of dental disorders, and the increasing surge in product approvals reflects advancements in orthopedic and dental technology, improving patient outcomes and thus expanding the market for osseointegration implants during the forecast period from 2024 to 2030.

4. Who are the key players operating in the global osseointegration implants market?

Some of the key market players operating in the osseointegration implants are Medtronic, Stryker, Neoss, Onkos Surgical, CartiHeal Ltd., RevBio, Inc., ZimVie Inc., Zimmer Biomet, OSSTEM IMPLANT CO., LTD., CONMED Corporation., Smith & Nephew, BioHorizons, Camlog, Straumann AG Group, Align Technology, Inc., BEGO GmbH and Co. KG, MEGA’GEN IMPLANT CO.,LTD., Henry Schein, Inc., MIS Implants Technologies, Nobel Biocare, and others.

5. Which region has the highest share in the global osseointegration implants market?

North America is expected to account for the highest proportion of the osseointegration implants market in 2023, out of all regions. The market for osseointegration implants in the North America is driven by several key factors such as orthopedic and dental disorders due to conditions such as osteoarthritis, osteoporosis, and tooth loss. Additionally, increasing technological advancements, and a viable market in terms of product approval and product launches will further boost the market for osseointegration implants


This product will be delivered within 2 business days.